PL EN
 
5/2009 vol. 63
Pobierz cytowanie
Carrier-state of the A allele of – 455G>A polymorphism within the beta fibrinogen gene increases the risk of coronary artery disease in the presence of elevated concentration of serum triacylglycerols
Beata Sarecka-Hujar 1
,
 
Iwona Zak 1
,
 
Jolanta Krauze 2
 
 
 
Więcej
Ukryj
1
Department of Biochemistry and Medical Genetics, School of Health Care, Medical University of Silesia, Katowice, Poland
 
2
The First Department of Cardiac Surgery, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland
 
 
Autor do korespondencji
Beata Sarecka-Hujar   

Department of Biochemistry and Medical Genetics, School of Health Care Medical University of Silesia, Kasztanowa Str. 3, 41-200 Sosnowiec, Poland; phone: (+48 32) 269 98 20
 
 
Ann. Acad. Med. Siles. 2009;63:41-49
 
Artykuł (PDF)
Referencje (36)
 
SŁOWA KLUCZOWE
choroba wieńcowa
polimorfi zm
fi brynogen beta
lipidy
tradycyjne czynniki ryzyka
 
STRESZCZENIE
Wstęp:
Fibrynogen promuje rozwój zmian miażdżycowych przez przyleganie do zmienionej ściany tętnic gdzie jest przekształcany w fi brynę. Celem niniejszej pracy była ocena związku między polimorfi zmem –455G>A genu kodującego łańcuch beta fi brynogenu (FGB) a ryzykiem choroby wieńcowej (CAD, ang. coronary artery disease) w grupie pacjentów z Górnego Śląska i ustalenie czy istnieją interakcje między tym polimorfi zmem a tradycyjnymi czynnikami ryzyka miażdżycy w determinowaniu ryzyka CAD.

Materiał i metody:
Grupę badaną stanowiło: 191 pacjentów z potwierdzoną koronarograficznie CAD oraz 203 krwiodawców bez obciążeń chorobami sercowo-naczyniowymi. Polimorfizm –455G>A genu FGB genotypowano metodą RFLP-PCR. Wyniki. Częstości genotypów polimorfizmu -455G>A genu FGB były zgodne z równowagą Hardy-Weinberg’a. Nie stwierdzono znamiennych różnic w częstości allela A i nosicieli allela A polimorfizmu genu FGB między pacjentami a grupą kontrolną. Obserwowano tendencję do występowania wyższego poziomu fi brynogenu w osoczu osób z genotypami AA i GA w porównaniu do poziomu fi brynogenu w osoczu osób z genotypem GG. Stwierdzono również silny synergiczny efekt między nosicielstwem allela A a podwyższonym poziomem triglicerydów w determinowaniu ryzyka CAD (indeksy synergii SI=5.97, SIM=2.63). Nosiciele allela A charakteryzujący się podwyższonym poziomem triglicerydów występowali trzykrotnie częściej w grupie chorych niż w kontroli (12.0% vs 3.9%, p=0.003,OR=3.34).

Wyniki:
Przedstawione wyniki wskazują na synergiczny związek nosicielstwa allela A polimorfizmu – 455G>A genu FGB z ponadnormatywnym stężeniem triglicerydów w surowicy krwi w kształtowaniu ryzyka CAD w populacji pacjentów z Górnego Śląska.

ISSN 0208-5607
REFERENCJE (36)
1.
Chung D.W., Harris J.E., Davie E.W. Nucleotide sequences of the three genes coding for human fi brinogen. Adv. Exp. Med. Biol. 1990; 281: 39-48.
Google Scholar
 
 
2.
Zhang J.Z., Redman C.M. Identifi cation of B beta chain domains involved in human fi brinogen assembly. J. Biol. Chem. 1992; 267: 21727-21732.
Google Scholar
 
 
3.
Bazzano L.A., He J., Muntner P., Vupputuri S., Whelton P.K. Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Ann. Intern. Med. 2003; 138: 891-897.
Google Scholar
 
 
4.
Thomas A.E., Green F.R., Kelleher C.H. i wsp. Variation in the promoter region of the beta fi brinogen gene is associated with plasma fi brinogen levels in smokers and non-smokers. Thromb. Haemost. 1991; 65:487-490.
Google Scholar
 
 
5.
Tybjaerg-Hansen A., Agerholm-Larsen B., Humphries S.E., Abildgaard S., Schnohr P., Nordestgaard B.G. A common mutation (G-455--> A) in the beta-fi brinogen promoter is an independent predictor of plasma fi brinogen, but not of ischemic heart disease. A study of 9,127 individuals based on the Copenhagen City Heart Study. J. Clin. Invest. 1997; 99: 3034- 3039.
Google Scholar
 
 
6.
Smith E.B., Keen G.A., Grant A., Stirk C. Fate of fi brinogen in human arterial intima. Arteriosclerosis 1990; 10:263-275.
Google Scholar
 
 
7.
Lindsberg P.J., Grau A.J. Infl ammation and infections as risk factors for ischemic stroke. Stroke 2003; 34: 2518-2532.
Google Scholar
 
 
8.
Behague I., Poirier O., Nicaud V. i wsp. Beta fi brinogen gene polymorphisms are associated with plasma fi brinogen and coronary artery disease in patients with myocardial infarction. The ECTIM Study. Etude Cas-Temoins sur l‘Infarctus du Myocarde. Circulation 1996; 93: 440-449.
Google Scholar
 
 
9.
Hamsten A., Iselius L., de Faire U., Blomback M. Genetic and cultural inheritance of plasma fi brinogen concentration. Lancet 1987; 2: 988-991.
Google Scholar
 
 
10.
Dalmon J., Laurent M., Courtois G. The human beta fi brinogen promoter contains a hepatocyte nuclear factor 1-dependent interleukin-6-responsive element. Mol. Cell Biol. 1993; 13: 1183-1193.
Google Scholar
 
 
11.
Judkin M.P., Gander M.P. Prevention of complications of coronary arteriography. Circulation 1974; 49: 599-602.
Google Scholar
 
 
12.
Alpert J.S., Thygesen K. Myocardial infarction redefi ned – A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefi nition of Myocardial Infarction. Eur. Heart J. 2000; 21: 1502-1513.
Google Scholar
 
 
13.
Sarecka-Hujar B., Zak I., Krauze J. Interactions between rs5498 polymorphism in the ICAM1 gene and traditional risk factors infl uence susceptibility to coronary artery disease. Clin. Exp. Med. 2009; 9:117-124.
Google Scholar
 
 
14.
Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without the use of preparative centrifuge. Clin. Chem. 1972; 18: 499- 502.
Google Scholar
 
 
15.
Nishiuma S., Kario K., Yakushijin K. i wsp. Genetic variation in the promoter region of the beta-fi brinogen gene is associated with ischemic stroke in a Japanese population. Blood Coagul. Fibrinolysis 1998; 9:373-379.
Google Scholar
 
 
16.
Rothman K.J. Synergy and antagonism in cause-eff ect relationship. Am. J. Epidemiol. 1974; 99: 385-388.
Google Scholar
 
 
17.
Khoury M.J., Flanders W.D. Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: case-control studies with no controls! Am. J. Epidemiol. 1996; 144: 207-213.
Google Scholar
 
 
18.
Lam K.S., Ma O.C., Wat N.M., Chan L.C., Janus E.D. Beta-fi brinogen gene G/A-455 polymorphism in relation to fi brinogen concentrations and ischaemic heart disease in Chinese patients with type II diabetes. Diabetologia 1999; 42: 1250-1253.
Google Scholar
 
 
19.
de Maat M.P., Kastelein J.J., Jukema J.W. i wsp. -455G/A polymorphism of the beta-fi brinogen gene is associated with the progression of coronary atherosclerosis in symptomatic men: proposed role for an acute-phase reaction pattern of fi brinogen. REGRESS group. Arterioscler. Thromb. Vasc. Biol. 1998; 18: 265-271.
Google Scholar
 
 
20.
Bi S., Wang D., Li G., Wen S., Pan S. Beta-fi brinogen promoter -455 G/A (HaeIII) polymorphism prediction of plasma fi brinogen but not of ischemic cerebrovascular disease. Chin. Med. Sci. J. 2004; 19: 1-5.
Google Scholar
 
 
21.
Ando R., Doi M., Yamauchi K. i wsp. Association of beta-fi brinogen and factor VII polymorphism with plasma fi brinogen and factor VII levels, and no association of PAI-1 polymorphism with plasma PAI-1 levels in hemodialysis patients. Clin. Nephrol. 2002; 58: 25-32.
Google Scholar
 
 
22.
Lee A.J., Fowkes F.G., Lowe G.D., Connor J.M., Rumley A. Fibrinogen, factor VII and PAI-1 genotypes and the risk of coronary and peripheral atherosclerosis: Edinburgh Artery Study. Thromb. Haemost. 1999; 81: 553-560.
Google Scholar
 
 
23.
de Maat M.P., de Knijff P., Green F.R., Thomas A.E., Jespersen J., Kluft C. Genderrelated association between beta-fi brinogen genotype and plasma fi brinogen levels and linkage disequilibrium at the fi brinogen locus in Greenland Inuit. Arterioscler. Thromb. Vasc. Biol. 1995; 15: 856-860.
Google Scholar
 
 
24.
Thomas A., Lamlum H., Humphries S., Green F. Linkage disequilibrium across the fi brinogen locus as shown by fi ve genetic polymorphisms, G/A-455 (HaeIII), C/T- 148 (HindIII/AluI), T/G+1689 (AvaII), and BclI (beta-fi brinogen) and TaqI (alphafi brinogen), and their detection by PCR. Hum. Mutat. 1994; 3: 79-81.
Google Scholar
 
 
25.
Mannila M.N., Lovely R.S., Kazmierczak S.C. i wsp. Elevated plasma fi brinogen gamma‘ concentration is associated with myocardial infarction: eff ects of variation in fibrinogen genes and environmental factors. J. Thromb. Haemost. 2007; 5: 766-773.
Google Scholar
 
 
26.
Leander K., Wiman B., Hallqvist J., Falk G., De Faire U. The G-455A polymorphism of the fi brinogen Bbeta-gene relates to plasma fi brinogen in male cases, but does not interact with environmental factors in causing myocardial infarction in either men or women. J. Intern. Med. 2002; 252: 332-341.
Google Scholar
 
 
27.
Bots M.L., Elwood P.C., Salonen J.T. i wsp. Level of fi brinogen and risk of fatal and non-fatal stroke. EUROSTROKE: a collaborative study among research centres in Europe. J. Epidemiol. Community Health 2002; 56 Suppl 1: i14-8.
Google Scholar
 
 
28.
Mills J.D., Ariens R.A., Mansfi eld M.W., Grant P.J. Altered fi brin clot structure in the healthy relatives of patients with premature coronary artery disease. Circulation 2002; 106: 1938-1942.
Google Scholar
 
 
29.
Weng X., Cloutier G., Genest J. Jr. Contribution of the -455G/A polymorphism at the betafi brinogen gene to erythrocyte aggregation in patients with coronary artery disease. Thromb. Haemost. 1999; 82:1406- 1411.
Google Scholar
 
 
30.
Scarabin P.Y., Aillaud M.F., Amouyel P. i wsp. Associations of fi brinogen, factor VII and PAI-1 with baseline fi ndings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction. Thromb. Haemost. 1998; 80: 749-756.
Google Scholar
 
 
31.
Boekholdt S.M., Bijsterveld N.R., Moons A.H., Levi M., Buller H.R., Peters R.J. Genetic variation in coagulation and fi brinolytic proteins and their relation with acute myocardial infarction: a systematic review. Circulation 2001; 104: 3063-3068.
Google Scholar
 
 
32.
Koch W., Hoppmann P., Biele J., Mueller J.C., Schömig A., Kastrati A. Fibrinogen genes and myocardial infarction: a haplotype analysis. Arterioscler. Thromb. Vasc. Biol. 2008; 28: 758-763.
Google Scholar
 
 
33.
Choumerianou D.M., Maumus S., Skoumas J. et all. Polymorphisms associated with apolipoprotein B levels in Greek patients with familial hypercholesterolemia. Clin. Chem. Lab. Med. 2006; 44: 799- 806.
Google Scholar
 
 
34.
Zak I., Sarecka-Hujar B., Krauze J. Cigarette smoking, carrier state of A or G allele of 46A>G and 79C>G polymorphisms of beta2-adrenergic receptor gene, and the risk of coronary artery disease. Kardiol. Pol. 2008; 66: 380-386.
Google Scholar
 
 
35.
Zak I., Sarecka-Hujar B., Krauze J. Relationships between traditional risk factors and carrier-state of C allele of 1059G>C polymorphism in the C-reactive protein gene and the risk of coronary artery disease. Ann. Acad. Med. Siles. 2008; 62: 27- 33.
Google Scholar
 
 
36.
Zak I., Sarecka B., Krauze J. Synergistic eff ects between 561A >C and 98G> T polymorphisms of E-selectin gene and hypercholesterolemia in determining the susceptibility to coronary artery disease. Heart Vessels 2008; 23: 257-263.
Google Scholar
 
 
Udostępnij
Wyślij mailem
ARTYKUŁ POWIĄZANY
Rola 7α-hydroksylazy cholesterolu i genu CYP7A1 w fizjologii i patologii człowieka
Związane z wiekiem zmiany w układzie arginazy-NO-syntazy w grupie pacjentów z chorobą wieńcową współistniejącą z nadciśnieniem tętniczym
Indeksy
 
Indeks słów kluczowych
Indeks dziedzin
Indeks autorów
eISSN:1734-025X
Journals System - logo


© 2006-2024 Journal hosting platform by Bentus
Scroll to top